- Home
- RSF vs DXR Comparison
RSF vs DXR Comparison
Compare RSF & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$11.23
Company Overview
Basic Information| Metric | RSF | DXR |
|---|---|---|
| Founded | 2016 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.6M | 59.0M |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RSF | DXR |
|---|---|---|
| Price | $14.26 | $11.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.9K | ★ 40.0K |
| Earning Date | 01-01-0001 | 02-27-2026 |
| Dividend Yield | ★ 10.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.13 | $8.56 |
| 52 Week High | $15.07 | $14.76 |
Technical Indicators
Market Signals| Indicator | RSF | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 33.43 | N/A |
| Support Level | $14.13 | N/A |
| Resistance Level | $14.69 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 31.37 | 0.00 |
Price Performance
Historical Comparison RSF
DXR
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.